Acid-sensing ion channels (ASICs) are protongated Na + channels. They have been implicated with synaptic transmission, pain perception as well as mechanoperception. ASIC4 is the most recent member of this gene family. It shows expression throughout the central nervous system with strongest expression in pituitary gland. ASIC4 is inactive by itself and its function is unknown. Mutations in ion channel subunits, which are homologues of ASICs lead to neurodegeneration in Caenorhabditis elegans. It has, therefore, been speculated that similar mutations in ASICs may be responsible for neurodegeneration in humans. Here, we show that ASIC4 maps to the long arm of chromosome 2 in close proximity to the locus for paroxysmal dystonic choreoathetosis (PDC), a movement disorder with unknown cause. Ion channel genes have been shown to cause several other paroxysmal neurologic disorders and are important candidate genes for PDC. We established the genomic organisation of the ASIC4 gene and screened a PDC pedigree for mutations in the coding region. Although we identified three polymorphisms in the Cterminal part of the ASIC4 protein, these were not present in each affected subject in the PDC kindred we analysed. Therefore, although the ASIC4 gene is physically mapped to the PDC locus, our data indicates that ASIC4 gene mutation is not the cause of PDC. It remains to be established if mutations in ASIC4 or other ASIC subunits may cause neurological disorders. European Journal of Human Genetics (2001) 9, 672 ± 676.
Introduction
Protongated ion channels (ASICs) belong to the Mec/ENaC superfamily of amiloride-sensitive Na + channels. 1 ASICs are ligandgated ion channels and directly activated by a drop of extracellular pH. So far, six different ASICs encoded by four genes have been cloned (ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3, and ASIC4 1 ± 3 ), which assemble into multimeric channels. They are expressed in brain as well as in sensory neurones and have been implicated in the sensation of pain as well as in modulation of synaptic transmission. Synaptic vesicles are acidic (pH 5.5) and release of transmitter can, thus, lead to acidic transients in the synaptic cleft. 4 Therefore, ASICs may contribute to the excitation of neurones. Mutations in the epithelial Na + channel (ENaC), a homologue of ASICs mediating Na + reabsorption, lead either to channel activation and hypertension or channel inactivation and salt wasting in infancy 5 ± 7 . Mutations in homologues of ASICs from Caenorhabditis elegans cause swelling of neurones and neurodegeneration. 8, 9 These mutations lead to constitutive activation of the channels and constant inflow of cations. 10 Here we evaluate the potential role of ASIC4 in a neurological disorder. We mapped the gene for ASIC4 to chromosome 2q35-36, in the same region to which the movement disorder paroxysmal dystonic choreoathetosis (PDC; MIM no. 118800) (also known as FPD1, familial paroxysmal choreoathetosis, and PNKD, paroxysmal nonkinesigenic dystonia) 15 Amplification of ASIC4 exons from genomic DNA Individual ASIC4 exons and adjacent short intronic sequences were amplified by PCR from human genomic DNA using intronic oligonucleotide primers (See Figure 2) . The sequence of these primers and the corresponding PCR conditions are available from the authors upon request. After amplification and agarose gel purification, PCR products were directly sequenced using an ABI377 automated DNA sequencer.
Linkage analysis
Twopoint linkage analyses were done between ASIC4 codon 508/511 polymorphisms and PDC. We used the Fastlink program, an autosomal dominant model of disease inheritance, and assigned disease allele frequency of 0.001. We assigned genetic penetrance=0.90 for lodscore calculations. We observed two instances of probable incomplete genetic penetrance (subjects IV-2 and IV-3, Figure 4 ).
Results
Chromosomal mapping of the ASIC4 gene close to the PDC locus We mapped the gene for ASIC4 using the GeneBridge 4 radiation hybrid panel to the human genome. This placed the ASIC4 gene 4.5 cRad (corresponding to approximately 1.2 Mb) distal of the marker CHLC.GATA3F05 (also known as D2S433) with a lodscore >21. This corresponds to position 2q35-36 on the cytogenetic map ( Figure 1 ). Several diseases have been mapped to this interval, including Bjornstad Â s syndrome (MIM no. 262000) and paroxysmal dystonic choreoathetosis (PDC), a movement disorder with unknown cause. It is believed that PDC has its cause in altered metabolism in basal ganglia. 24, 25 Given the expression pattern of ASIC4 with expression throughout the nervous system, we considered the ASIC4 gene as a good candidate for PDC. We, therefore, analysed a BAC (bacterial artificial chromosome) contig containing the PDC locus for the presence of the ASIC4 gene. The PDC locus, extending from D2S295 to D2S163, is spanned by three BAC contigs (NT_005337, NT_022216 and NT_005289, Genbank). BLAST sequence analysis revealed that the entire ASIC4 gene was contained in two BACs (123-E1 and 158J14) and partially contained in two other BACs (256I23 and 316O14).
Screening of the ASIC4 coding region in a PDC kindred A PAC was isolated containing the entire ASIC4 coding region. The genomic structure of the ASIC4 gene was (Figure 2 ). Genomic sequences of the genome project, which became available in the public domain during the course of this study, confirm this structure. The whole gene has 10 exons and size of introns ranges from 84 to over 16 000 bp.
We sequenced the entire ASIC4 coding sequence as well as adjacent intronic sequences (Figure 2 ) in a DNA sample from an affected member of a large PDC family, in which the disorder had been shown to be linked to the PDC locus on chromosome 2 (D2S295 ± D2S163; Figure 1) . 15 Since PDC is transmitted as an autosomal dominant disorder, we were particularly interested in identifying heterozygous polymorphisms. Compared to the human cDNA sequence for ASIC4 2 , we identified one homozygous nucleotide exchange in the first exon, which did not change the amino acid (codon 38 changed from GCC to GCG). In addition, we identified one heterozygous polymorphism in exon 10 changing proline 506 into a glutamine. We refer to this site as the P/Q site. Finally, we identified two homozygous amino acid exchanges, at codon 508 changing leucine into arginine and at codon 511 changing alanine into valine. We refer to these sites as the L/R and the A/V site, respectively. These three mutations (codon 506 proline to glutamine, codon 508 leucine to arginine, and codon 511 alanine to valine) cluster in a region of only six amino acids contained in the last exon (Figure 3) . 
We then screened the last exon in the other 27 family members for the genotype at these three polymorphic sites. As we did not identify additional polymorphisms of the protein sequence we restricted screening to exon 10 containing these three polymorphisms. Figure 4 summarises the results from this screen. Ten members of the family show clinical symptoms of PDC, the others are not affected. 15 Only four subjects of the family are heterozygous at the P/Q site, two siblings in generation III and two related inividuals in generation IV (Figure 4) . One is an affected person, one is unaffected but passed the disease to her daughter and two are unaffected people. The others are all homozygous for the P. This shows that the P to Q change cannot account for the disease. We identified also individuals heterozygous at the L/ R and A/V sites. The R was always linked to the V: the haplotype is L-A on one allele and R-V on the other. As with the P to Q change, the L to R change and its linked A to V change were not disease specific: each was present in both affected and unaffected individuals. Allele frequencies were determined in a cohort of 26 unrelated subjects. P and Q alleles were 58% and 42%, respectively; RV and LA alleles were 56% and 44%, respectively. Two-point linkage analysis was performed using the syntenic polymorphisms at codons 508 and 511 (subjects determined to be either 508 Leu /511 Ala or 508 Arg /511 Val ) ( Figure 4 ) and assigning genetic penetrance = 0.9. These polymorphisms were largely uninformative with only several informative subjects. Nonetheless, we obtained a lodscore of +1.68 at y = 0. The absence of obligate recombinants suggests that ASIC4 is linked to PDC and is consistent with the finding that the ASIC4 gene is contained in two BAC clones of the PDC contig (discussed above).
Discussion
We show that the ASIC4 gene maps to 2q35-36 on the long arm of chromosome 2. PDC has been mapped to this region 15, 16 and the locus reduced to the 2.7 cM interval between D2S295 and D2S163 26,27 ( Figure 1 ). Moreover, ASIC4 was identified as being within a BAC contig containing the PDC disease gene, showing that ASIC4 maps within the PDC locus on chromosome 2. We identified three amino acid substituting ASIC4 gene polymorphisms in the initial subject, for whom we sequenced the entire ASIC4 coding region. One was a heterozygous mutation (changing proline to glutamine at codon 506) and the other two were homozygous mutations (at codons 508 and 511). Since PDC is dominantly inherited, Figure 4 Segregation of ASIC4 coding sequence polymorphisms with paroxysmal dystonic choreoathetosis. Genotypes are shown for polymorphisms at codon 506 (proline/glutamine), codon 508 (arginine/leucine), and codon 511 (alanine/valine). Disease alleles are enclosed by boxes. Polymorphisms have initially been identified in subject III-3.
European Journal of Human Genetics ASIC4 gene as a candidate for PDC S Gru Ènder et althe heterozygous mutation at codon 506 was considered the more likely candidate to account for the PDC phenotype. None of these polymorphisms was disease specific: both wildtype and mutant alleles were found in affected and unaffected subjects. Moreover, we identified these polymorphisms also in unrelated subjects not showing any symptoms of PDC, suggesting that these are rather common polymorphisms. Our data does not support a role for ASIC4 coding sequence mutations in PDC.
Sequence conservation between human and rat ASIC4 is high; both proteins are 97% identical. 2 The three polymorphisms we identified map to a region, which shows comparatively high sequence divergence. This may indicate that these polymorphisms do not interfere with normal channel activity. We show that although ASIC4 maps within the PDC locus on chromosome 2, we did not identify disease (PDC) specific ASIC4 coding sequence mutations. Consensus sites for splicing at the borders of introns were also identical between affected and unaffected family members. We cannot exclude, however, that mutations in other noncoding portions of ASIC4 could contribute to PDC. Closer evaluation of ASIC4 and other ASIC genes will show if mutations in ASICs lead to neurodegeneration or other neurological disorders.
